Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Moonsoo M. Jin"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Ionizing radiation has garnered considerable attention as a combination partner for immunotherapy due to its potential immunostimulatory effects. In contrast to the more commonly used external beam radiation, we explored the feasibility of combining
Externí odkaz:
https://doaj.org/article/1ccec8cc7cc44b3797789c2f3d40aca8
Autor:
Yanping Yang, Huan Yang, Yago Alcaina, Janusz Puc, Alyssa Birt, Yogindra Vedvyas, Michael Gallagher, Srinija Alla, Maria Cristina Riascos, Jaclyn E. McCloskey, Karrie Du, Juan Gonzalez-Valdivieso, Irene M. Min, Elisa de Stanchina, Matt Britz, Eric von Hofe, Moonsoo M. Jin
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract The limited number of targetable tumor-specific antigens and the immunosuppressive nature of the microenvironment within solid malignancies represent major barriers to the success of chimeric antigen receptor (CAR)-T cell therapies. Here, us
Externí odkaz:
https://doaj.org/article/1773c1a113ad431dbfb194f4da0fc107
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract The ability to image adoptively transferred T cells in the body and to eliminate them to avoid toxicity will be vital for chimeric antigen receptor (CAR) T cell therapy, particularly against solid tumors with higher risk of off-tumor toxicit
Externí odkaz:
https://doaj.org/article/b4d931c057124558b1311f10901b0857
Autor:
Minkyu Jung, Yanping Yang, Jaclyn E. McCloskey, Marjan Zaman, Yogindra Vedvyas, Xianglan Zhang, Dessislava Stefanova, Katherine D. Gray, Irene M. Min, Raza Zarnegar, Yoon Young Choi, Jae-Ho Cheong, Sung Hoon Noh, Sun Young Rha, Hyun Cheol Chung, Moonsoo M. Jin
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 587-601 (2020)
Cancer therapy utilizing adoptive transfer of chimeric antigen receptor (CAR) T cells has demonstrated remarkable clinical outcomes in hematologic malignancies. However, CAR T cell application to solid tumors has had limited success, partly due to th
Externí odkaz:
https://doaj.org/article/2d219804286b4b9eabd7428add107045
Autor:
Alejandro Amor-Coarasa, James M. Kelly, Pradeep K. Singh, Shashikanth Ponnala, Anastasia Nikolopoulou, Clarence Williams, Yogindra Vedvyas, Moonsoo M. Jin, J. David Warren, John W. Babich
Publikováno v:
Molecules, Vol 24, Iss 8, p 1612 (2019)
Determining chemokine receptor CXCR4 expression is significant in multiple diseases due to its role in promoting inflammation, cell migration and tumorigenesis. [68Ga]Pentixafor is a promising ligand for imaging CXCR4 expression in multiple tumor typ
Externí odkaz:
https://doaj.org/article/5a56847e5c1d40c8832a2599259bda54
Autor:
Jessica Limberg, Caitlin E. Egan, Katherine D. Gray, Mandeep Singh, Zachary Loewenstein, Yanping Yang, Maria Cristina Riascos, Hala Al Asadi, Parima Safe, Steve El Eshaky, Heng Liang, Timothy M. Ullmann, Weibin Wang, Wei Li, Tuo Zhang, Jenny Xiang, Dessislava Stefanova, Moonsoo M. Jin, Rasa Zarnegar, Thomas J. Fahey, Irene M. Min
Publikováno v:
Molecular Cancer Research. 21:397-410
A subset of thyroid cancers, recurrent differentiated thyroid cancers and anaplastic thyroid cancer (ATC), are difficult to treat by thyroidectomy and systemic therapy. A common mutation in thyroid cancer, BRAFV600E, has targetable treatment options;
Publikováno v:
iLABMED.
Autor:
Irene M. Min, Thomas J. Fahey, Rasa Zarnegar, Moonsoo M. Jin, Dessislava Stefanova, Jenny Xiang, Tuo Zhang, Wei Li, Weibin Wang, Timothy M. Ullmann, Heng Liang, Steve El Eshaky, Parima Safe, Hala Al Asadi, Maria Cristina Riascos, Yanping Yang, Zachary Loewenstein, Mandeep Singh, Katherine D. Gray, Caitlin E. Egan, Jessica Limberg
S1. BRAFV600E mutation identified in thyroid cancer cell lines analyzed by RNA-seq.S2. STR analysis in thyroid cancer cell lines used in this study.S3. Gene expression of thyroid-specific genes in thyroid cancer cell lines analyzed by RNA-seq.S4. Dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c03a3039ae476a972e72bf0da1627b
https://doi.org/10.1158/1541-7786.22725440.v1
https://doi.org/10.1158/1541-7786.22725440.v1
Autor:
Irene M. Min, Thomas J. Fahey, Rasa Zarnegar, Moonsoo M. Jin, Dessislava Stefanova, Jenny Xiang, Tuo Zhang, Wei Li, Weibin Wang, Timothy M. Ullmann, Heng Liang, Steve El Eshaky, Parima Safe, Hala Al Asadi, Maria Cristina Riascos, Yanping Yang, Zachary Loewenstein, Mandeep Singh, Katherine D. Gray, Caitlin E. Egan, Jessica Limberg
Supplementary Table 1. Gene expression changes in 8505C after vemurafenib treatment.Supplementary Table 2. Gene expression changes in WRO after vemurafenib treatment.Supplementary Table 3. Gene expression changes in 8505C -Vem-Res 1 relative to paren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b6b2bf942c9fc01ea3a25256b6cd0c
https://doi.org/10.1158/1541-7786.22725437
https://doi.org/10.1158/1541-7786.22725437
Autor:
Moonsoo M. Jin, Eric von Hofe, Irene M. Min, Elisa de Stanchina, Elizabeth Ortiz-Sánchez, Angel A. Gomez Gallegos, Yogindra Vedvyas, Yago Alcaina, Janusz Puc, Huan Yang, Jaclyn E. McCloskey, Yanping Yang
Supplementary figure S1-S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29dfdb9e9b827e7f29066eba501eb4c2
https://doi.org/10.1158/2326-6066.22543752
https://doi.org/10.1158/2326-6066.22543752